Alterity Therapeutics Limited (ATH, formerly Prana Biotechnology Limited) is an Australian biotechnology company which focusses to commercialise research into Parkinsonian movement disorders, Alzheimer's disease, Huntington disease and other neurodegenerative disorders.
Alterity Therapeutics
Follow
Get notifications in MyBN when activity occurs.
Company Activity
NEWS: Tagged in Investors encouraged not to sleep on medtechs | 08 Dec 2023 | |
NEW ROLE: Dianne Angus, Chief Operating Officer | 24 Nov 2020 | |
NEW ROLE: Kathryn Andrews, Chief Financial Officer | 24 Nov 2020 | |
NEW ROLE: David Stamler, Chief Medical Officer | 24 Nov 2020 | |
NEW ROLE: Brian D Meltzer, Non-Executive Director | 03 Nov 2020 | |
NEW ROLE: Peter Marks, Non-Executive Director | 03 Nov 2020 | |
NEW ROLE: Lawrence Gozlan, Non-Executive Director | 03 Nov 2020 | |
NEW ROLE: Tristan Edwards, Non-Executive Director | 03 Nov 2020 | |
NEW ROLE: Phillip Hains, Company Secretary | 03 Nov 2020 |